6
PYFA0309.TXT

PYFA
Pyridam Farma Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Sep-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 9

Summary of Balance Sheet
  Receivables               :       5,877,690.19
  Inventories               :       6,305,136.05
  Current Assets            :      13,370,313.74
  Fixed Assets              :      56,699,201.44
  Other Asstes              :               0.00
  Total Assets              :      70,502,941.15
  Current Liabilities       :       6,421,239.11
  Longterm Liabiities       :       3,042,388.39
  Total Liabilities         :       9,463,627.51
  Authorized                :       1,600,000.00
  Paid-up Capital           :      53,508,000.00
  Par Value                 :                100
  Paid-up Capital Shares    :         535,080.00
  Retained Earnings         :       5,466,235.14
  Total Equity              :      61,039,313.64
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :      20,438,743.30
  Cost of Good Sold         :       7,497,862.16
  Gross Profit              :      12,940,881.15
  Operating Profit          :       1,923,306.41
  Other Income              :        -384,882.77
  Eearning Before Tax       :       1,538,423.64
  Tax                       :         591,556.51
  Net Income                :         946,867.13
  Closing Price             :             195.00

Per Share Data (Rp)
  Eps                       :               2.36
  Book Value                :             114.08

Financial Ratios
  Debt Equity Ratio (X)     :                .16
  Roa (%)                   :               1.79
  Roe (%)                   :               2.07
  Npm (%)                   :               6.18
  Opm (%)                   :              12.55

Cash Flow
  CF from Operating Activities                        :       4,838,148.12
  CF from Investing Activities                        :      -1,886,286.57
  CF from Financing Activities                        :      -3,035,467.59
  Net Increase in Cash & Cash Equivalent              :         -83,606.04
  Cash & Cash Equivalent at The Beginning of The Year :         831,256.76
  Cash & Cash Equivalent at The End of The Year       :         747,650.73

 
 
 
